Abstract
Nasopharyngeal carcinoma (NPC) is highly prevalent in southern China and Southeast Asia. Cancer resistance to therapy, metastasis and disease recurrence are significant hurdles to successful treatment of NPC. Identifying mechanisms by which NPC is resistant is critical to improving patient survival. Evidence gathered in the last decade suggests that tumor progression and recurrence may be fuelled by cancer stem cells (CSCs). Understanding how CSCs contribute to the pathology of NPC will potentially aid the pursuit of novel therapies. In this review we summarize what major methods are currently used to identify CSCs in NPC and the challenges faced.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
